Why This Doctor Came Out of Retirement

Meet Dr. John Catanzaro, CEO of Neo7Bioscience, pioneer in precision molecular medicine, specializing in personalized peptide engineering and OMICS-driven therapeutics. After 25 years leading integrative oncology, he was called back from retirement to revolutionize how we fight cancer through molecular-level insights, AI-powered platforms, and patient-specific therapies. Discover what your body’s unique molecular signals reveal about your health in Episode 36, What Your Urine & Tumor Tissue Reveal About Your Cancer!

⏰ Catch the full episode now on Rumble or listen at https://www.beljanski.org/podcast

#PrecisionMedicine #PersonalizedTherapy